An Act further regulating the substitution of interchangeable biosimilars
By Mr. Cusack of Braintree, a petition (accompanied by bill, House, No. 976) of Mark J. Cusack relative to the substitution of interchangeable biosimilars. Health Care Financing.
Bill Information
Bill Information
- Presenter:
- Mark J. Cusack
- Status:
- Referred to House Committee on Bills in the Third Reading
Bill History
| Date | Branch | Action |
|---|---|---|
| 1/20/2015 | House | Referred to the committee on Health Care Financing |
| 1/20/2015 | Senate | Senate concurred |
| 10/5/2015 | Joint | Hearing scheduled for 10/13/2015 from 11:00 AM-03:00 PM in B-2 |
| 6/20/2016 | House | Committee reported that the matter be placed in the Orders of the Day for the next sitting |
| 6/20/2016 | House | Read second and ordered to a third reading |
| 6/20/2016 | House | Rules suspended |
| 1/3/2017 | House | No further action taken |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.